Q2 2020

Filed Aug 20, 2020 · 10-Q · 51 days after period end · 0001654954-20-009366

Q2 2020 · 10-Q

Revenue

$0.00

−100.0% vs Q2 2019

Net Income

-$6.75M

N/M vs Q2 2019

EPS Diluted

-$0.57

N/M vs Q2 2019

Gross Profit-$6,000N/M

Operating Income

Same quarter

Metric	Q2 2020	Q2 2019	Q2 2018	Q2 2017
Revenue	$0.00	$1.00K	$8.00K	$87.00K
Net Income	-$6.75M	-$2.66M	$3.42M	-$1.07M
EPS Diluted	-$0.57	-$0.81	$1.24	-$0.59

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR